Cell Therapeutics Enters $15M Loan Financing Agreement with Hercules Technology Growth Capital

By: Benzinga
Cell Therapeutics (NASDAQ: CTIC ) announced today it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC ) providing for a senior secured term loan of up to $15 million. "The proceeds from this loan facility are expected to provide us with additional
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.